Dispatch Biotherapeutics Inc. is taking aim at solid tumors with a new viral vector/antigen technology backed by major industry names such as Arch Venture Partners and Bristol Myers Squibb Co. With ...

Some of the biggest players in artificial intelligence continued to ramp up their spending on federal lobbying last quarter, ...